Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-2079
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-10-21T06:54:35.881965Z
status: published
lens: trace
sector: health
headline: Feasibility of an Activity Control System in Patients with Type 2 Diabetes: Results from a Non-Randomised Controlled Pilot Study
dek: Objective Diabetes mellitus (DM) is a disease that requires continuous, active management by the patient, encompassing lifestyle and activities of daily living (ADL). There is limited evidence and a scarcity of devices that monitor ADL in patients with DM using artificial intelligence-based technology. This study evaluates the feasibility of the AI2EPD home activity monitoring system, focusing on therapeutic adherence in the treatment of people with DM2. Methods A pilot-controlled study was conducted. Vibration…
gain_title: Participants in the intervention group found the AI-based home monitoring system easy to use and safe, indicating high acceptance and feasibility for people with type 2 diabetes.
problem_title: The pilot found no clinical benefit attributable to the monitoring system, and the only significant HbA1c improvement occurred in the control group.
trace_subject: AI2EPD home activity monitoring system for adherence in type 2 diabetes
gain_reading: Participants in the intervention group found the AI-based home monitoring system easy to use and safe, indicating high acceptance and feasibility for people with type 2 diabetes.
gain_evidence: The intervention group found the system easy to use and safe, indicating high acceptance. | The use of the AI2EPD intelligent remote monitoring system in the home was feasible and well accepted by participants.
problem_reading: The pilot found no clinical benefit attributable to the monitoring system, and the only significant HbA1c improvement occurred in the control group.
problem_evidence: No clinical benefit attributable to the intervention was demonstrated. | The only statistically significant within-group improvement in HbA1c was observed in the control group
quick_read: Researchers ran a small non-randomised controlled pilot of AI2EPD, a home system combining vibration and motion sensors, activity bracelets and an AI web platform, to support treatment adherence in people with type 2 diabetes. Twenty-one people took part, ten in the intervention arm and eleven in the control arm.

The study suggests that such AI-enabled home monitoring can be accepted by patients, which is a precondition for wider use. But acceptance did not translate into measurable clinical improvement here, so whether the approach helps manage diabetes remains unanswered until larger, adequately powered studies are done.
limitation: The study was a small, non-randomised pilot with multiple exploratory comparisons, so its clinical findings must be interpreted with caution and need confirmation in adequately powered studies.
tag: Dual reading
key_points: The AI2EPD system combined home vibration and motion sensors, physical activity bracelets and an AI web system. | Twenty-one participants were enrolled: 10 in the intervention group and 11 in the control group. | Clinical results were similar across both groups, with no clinical benefit attributable to the intervention. | Evaluation used scales covering usability, medication adherence, comorbidity, self-care, diabetes knowledge, physical activity and quality of life. | The authors call for adequately powered studies to evaluate exploratory adherence and clinical findings.
rundown: The study targeted a gap: diabetes needs continuous patient-led management of lifestyle and daily activities, yet there is limited evidence and few devices that monitor daily living activities in people with diabetes using artificial intelligence.

Outcomes were assessed with the System Usability Scale, Morisky-Green Test, Charlson Comorbidity Index, a Spanish version of the Summary of Diabetes Self-Care Activities Measure, the Diabetes Knowledge Questionnaire, the International Physical Activity Questionnaire and EuroQol 5D.

On results, the intervention group rated the system easy to use and safe. The only statistically significant within-group HbA1c improvement was in the control group, which the authors say should be interpreted cautiously given the pilot design and multiple exploratory comparisons.
sources:
- peer_reviewed | Endocrine Practice | https://doi.org/10.1016/j.eprac.2026.10.007 | 2026-10-19
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

2e5cad8878f691b344feab6fb2f750793882502ed2b2e0921f9dcc62180e28cf

previous

0000000000000000000000000000000000000000000000000000000000000000